Clinical trial: Observational, Prospective, Multicenter Study of Epidyolex® (Cannabidiol CBD 100 mg/ml) Oral Solution, as Adjunctive Treatment for Seizures Associated With Lennox- Gastaut Syndrome (LGS), Dravet Syndrome (DS) and Tuberous Sclerosis Complex (TSC)

https://clinicaltrials.gov/study/NCT05485831?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18669

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology